Companies: 10,795·Total market cap: $144.5T
Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc.

RCKTNASDAQHealthcare● Active
$2.70
$-0.05(-1.82%)
Market Cap$294822582
P/E Ratio
52W High$5.45
52W Low$2.4

Rocket Pharmaceuticals, Inc.(RCKT)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · RCKT · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.01B$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.01B)$0.00B$0.00B$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.14B$0.17B$0.19B$0.17B$0.13B
G&A Expenses$0.09B$0.10B$0.07B$0.06B$0.04B
Total Operating Expenses$0.22B$0.27B$0.26B$0.22B$0.17B
Operating Income($0.23B)($0.27B)($0.26B)($0.22B)($0.17B)
Operating Margin %(computed)
Interest Income$0.01B$0.02B$0.02B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.01B
Income Before Tax($0.22B)($0.26B)($0.25B)($0.22B)($0.17B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.22B)($0.26B)($0.25B)($0.22B)($0.17B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-2.01$-2.73$-2.92$-3.26$-2.68
Wtd Avg Shares0.11B0.09B0.08B0.07B0.06B
EBITDA($0.21B)($0.25B)($0.24B)($0.21B)($0.16B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Rocket Pharmaceuticals, Inc.

关于Rocket Pharmaceuticals, Inc.(RCKT)损益表

Rocket Pharmaceuticals, Inc.(RCKT)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,RCKT实现营收$0.00B,毛利润($0.01B)(毛利率—),净利润($0.22B)(净利率—)。

常见问题

RCKT · 4 问

Rocket Pharmaceuticals, Inc.(RCKT)2025财年营收为$0.00B,同比down—%。

RCKT revenueRCKT salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08